Impact of new oral or intravenous P2Y12 inhibitors and clopidogrel on major ischemic and bleeding events in patients with coronary artery disease: a meta-analysis of randomized trials.

Tang, Xiao-Fang

Impact of new oral or intravenous P2Y12 inhibitors and clopidogrel on major ischemic and bleeding events in patients with coronary artery disease: a meta-analysis of randomized trials. [electronic resource] - Atherosclerosis Apr 2014 - 568-578 p. digital

Publication Type: Comparative Study; Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review

1879-1484

10.1016/j.atherosclerosis.2014.01.017 doi


Acute Coronary Syndrome--epidemiology
Adenosine--administration & dosage
Adenosine Monophosphate--administration & dosage
Administration, Oral
Clopidogrel
Coronary Artery Disease--complications
Coronary Restenosis--prevention & control
Fibrinolytic Agents--adverse effects
Hemorrhage--chemically induced
Humans
Injections, Intravenous
Multicenter Studies as Topic--statistics & numerical data
Myocardial Infarction--epidemiology
Piperazines--administration & dosage
Prasugrel Hydrochloride
Purinergic P2Y Receptor Antagonists--administration & dosage
Quinazolinones--administration & dosage
Randomized Controlled Trials as Topic--statistics & numerical data
Stents
Stroke--epidemiology
Sulfonamides--administration & dosage
Thiophenes--administration & dosage
Thrombolytic Therapy--adverse effects
Ticagrelor
Ticlopidine--adverse effects